PTGS2 and cancer: Taking into account the growing interest of scientific community in studying the potential anticancer activity of COX-2 inhibitors, the authors evaluated anti-inflammatory and also COX inhibitory activity of compounds 10a–10g (Figure 12 and Figure 13) that possessed the best anticancer profile against a panel of cancer cell lines (MCF-7, HT-29, A549).